Streetbeat News

Stock Prices

SPY

The Dallas Fed Manufacturing Business Index for July dropped to -17.5 from -15.1 in the previous month, indicating a further contraction in manufacturing activity.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 2:31 pm

TOL

Whales have taken a bearish stance on Toll Brothers (NYSE:TOL), with 40% of recent options trades being bearish. The major market movers are focusing on a price band between $85.0 and $150.0. Analysts have mixed ratings, with price targets ranging from $116 to $180.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 2:30 pm

IREN

High-rolling investors have shown a bearish sentiment on Iris Energy (NASDAQ:IREN) through significant options trading. The sentiment is split with 37% bullish and 50% bearish. The trading activity suggests a price target range of $9.0 to $17.5. Analysts have mixed ratings with a consensus target price of $19.2.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 2:30 pm

ARLP

Alliance Resource shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY24 revenue guidance for its coal operations.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 2:29 pm

SNDX

Syndax Pharmaceuticals shares are trading lower after the FDA extended the review period for the company's leukemia drug Revumenib.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 2:28 pm

IART

Integra LifeSciences shares are trading lower after the company lowered its FY24 guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 2:28 pm

MCD

McDonald's shares are trading higher, reversing after an initial drop due to a Q2 earnings miss.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 2:24 pm

SLRX

Salarius Pharmaceuticals (SLRX) shares have resumed trading after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 2:16 pm

CERO

CGTX

LIPO

MCD

TWOU

VTVT

YIBO

U.S. stocks traded higher with the Nasdaq Composite gaining around 1%. McDonald's posted worse-than-expected Q2 results, leading to a decline in its stock. Lipella Pharmaceuticals, Planet Image International, and 2U, Inc. saw significant gains, while vTv Therapeutics, Cognition Therapeutics, and CERo Therapeutics experienced notable declines.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 2:12 pm

SLRX

Salarius Pharmaceuticals shares were halted on a circuit breaker to the downside but have since rebounded and are now up 19.1%.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 2:12 pm